The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.

The largest deal of the week is a global development and commercialization agreement for DS-1062 between AstraZeneca plc and Daiichi Sankyo Company valued at $1 billion. DS-1062 is Daiichi Sankyo’s proprietary trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC), and potential new medicine for the treatment of multiple tumor types. The companies will jointly develop and commercialize DS-1062 worldwide, except in Japan where Daiichi Sankyo will maintain exclusive rights. AstraZeneca and Daiichi Sankyo will share equally development and commercialization expenses as well as profits relating to DS-1062 worldwide, except for Japan.

To subscribe to our Health Care M&A deals chart and more, visit our membership is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.

Click here to view our quarterly and annual publications and here to view our monthly webinar series.

Behavioral Health Care    
Acquirer Target Price
WindRose Health Investors, LLC Caregiver Inc. N/A
Acquirer Target Price
AstraZeneca plc DS-1062 development and commercialization agreement $1,000,000,000
Atsena Therapeutics Rights to Gene Therapy for GUCY2D N/A
Arya Sciences Acquisition Corp II Cerevel Therapeutics, Inc. N/A
Genentech, Inc. License to UCB0107 $120,000,000
Acquirer Target Price
Ciox Health Medal, Inc. N/A
Sharecare, Inc. WhiteHatAI N/A
TA Associates & Francisco Partners Edifecs, Inc. N/A
Healthcare Merger Corp. Specialists On Call, Inc. $720,000,000
Strata Decision Technology EPSi $365,000,000
Laboratories, MRI and Dialysis    
Acquirer Target Price
Recursion Vium N/A
Long-Term Care    
Acquirer Target Price
Local buyer Chelsea of Jenkintown $3,000,000
Acquirer Target Price
Stanley Capital Noden $45,000,000
Physician Medical Groups    
Acquirer Target Price
MB2 Dental Solutions Lake Erie Dental N/A
Other Services    
Acquirer Target Price
LGM Pharma Nexgen Pharama CDMO business N/A
Methodist Healthcare System 5 freestanding emergency centers N/A
Stage Equity Partners 2 MOBs in Texas N/A
IRA Capital Paramount Surgery Center $7,000,000